1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Ductal AdenocarcinomaRecruitingPhase 1 / Phase 22026-05-22NCT05688215